Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Saladax Biomedical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12119
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, MyPaclitaxel is blood test used to measure exposure of patient to paclitaxel, and MyDocetaxel measures patient’s exposure to docetaxel. Saladax’s MyImatinib measures and helps physicians to optimize a patient’s exposure to imatinib. The company’s products are used in the treatment of cell lung cancer, digestive tract, prostate, and head and neck cancers. It markets its products in the US and abroad. Saladax is headquartered in Bethlehem, Pennsylvania, the US.

Saladax Biomedical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Saladax Biomedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Saladax Biomedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Saladax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Saladax Biomedical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 10
Partnerships 12
Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 12
Siemens Healthcare Enters into Licensing Agreement with Saladax Biomedical 13
Saladax Biomedical Enters Into Distribution Agreement With Transmedic For Oncology Dosing Assays 14
Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb 15
Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios Biomedical Diagnostics For My5-FU 16
Equity Offering 17
Saladax Biomedical Raises USD22.4 Million in Private Placement 17
Saladax Biomedical Inc – Key Competitors 18
Saladax Biomedical Inc – Key Employees 19
Saladax Biomedical Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Saladax Biomedical Inc, Medical Equipment, Key Facts 2
Saladax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Saladax Biomedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Saladax Biomedical Inc, Deals By Market, 2012 to YTD 2018 8
Saladax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 10
Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 12
Siemens Healthcare Enters into Licensing Agreement with Saladax Biomedical 13
Saladax Biomedical Enters Into Distribution Agreement With Transmedic For Oncology Dosing Assays 14
Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb 15
Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios Biomedical Diagnostics For My5-FU 16
Saladax Biomedical Raises USD22.4 Million in Private Placement 17
Saladax Biomedical Inc, Key Competitors 18
Saladax Biomedical Inc, Key Employees 19

List of Figures
Saladax Biomedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Saladax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Saladax Biomedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Saladax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Saladax Biomedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tokyo Electric Power Company Holdings Incorporated (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Incorporated (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • International Business Machines Corporation:企業の戦略・SWOT・財務情報
    International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report Summary International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Nobility Homes Inc (NOBH):企業の財務・戦略的SWOT分析
    Nobility Homes Inc (NOBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Johnston Press plc:企業の戦略的SWOT分析
    Johnston Press plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Hitachi Capital (UK) PLC:企業の戦略・SWOT・財務情報
    Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report Summary Hitachi Capital (UK) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance serv …
  • Nymox Pharmaceutical Corp (NYMX)-医療機器分野:企業M&A・提携分析
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …
  • BFS Group Ltd:企業の戦略・SWOT・財務分析
    BFS Group Ltd - Strategy, SWOT and Corporate Finance Report Summary BFS Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • PCM Inc:企業の戦略・SWOT・財務情報
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Breckenridge Pharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Breckenridge Pharmaceutical Inc (Breckenridge), a subsidiary of Laboratorios Del Dr Esteve SA is a healthcare solution provider that research, develops and markets various generic prescription products. The company provides products including stradiol, oxcarbazepine tablets, methylprednisolo …
  • Kuwait Projects Company Holding KSC (KPROJ):企業の財務・戦略的SWOT分析
    Kuwait Projects Company Holding KSC (KPROJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Itau Unibanco Holding SA:企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GridPoint, Inc.-エネルギー分野:企業M&A・提携分析
    Summary GridPoint, Inc. (Gridpoint), a subsidiary of Twenty First Century Utilities LLC, is a provider of data-driven energy management systems. The company offers a wide range of energy management hardware including control, equipment-level sub-metering and advanced monitoring devices such as contr …
  • Vifor Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Vifor Pharma AG (Vifor Pharma), a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tr …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a provider of instruments, reagents, and services for molecular profiling applications. The company's products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provid …
  • Lifeway Foods Inc:企業の戦略・SWOT・財務情報
    Lifeway Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Lifeway Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ION Geophysical Corp (IO):石油・ガス:M&Aディール及び事業提携情報
    Summary ION Geophysical Corp (ION) is a provider of seismic solutions. It offers geoscience products, services and solutions to the global oil and gas industry. The company acquires, process and interpret data from seismic surveys in regional data programs, which become part of the multi-client data …
  • Entasis Therapeutics Inc (ETTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Entasis Therapeutics Inc (Entasis) is a drug development company that discovers and develops anti-infective therapies for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, ETX0282, ETX0914 and Zoliflodacin. Its ETX2514 is a potent inhibitor of class A, C, …
  • Gold Road Resources Ltd (GOR):企業の財務・戦略的SWOT分析
    Summary Gold Road Resources Ltd (GRRL), formerly Eleckra Mines Ltd, is a mining and mineral exploration and development company that offers mining services. The company acquires, explores and develops iron, gold, nickel and mineral deposits properties. Its projects comprise Gruyere project, Yamarna …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆